Aller au contenu

Publications scientifiques

  • article Khataei S, Jafari K, Fortier C, Philibert E, de Rico E, Spronck B, Guidici A, Obeid H, Addour S, Bujold E, Goupil R, Agharazii M

    Assessing vascular health by measuring arterial stiffness in response to hemodynamic load

    J Hypertens 44 (3), 2026.

  • article Hundemer GL, Desbiens LC, Agharazii M, Madore F, Vaidya A, Leung AA, Kline GA, Sood MM, Akbari A, White C, Glassman I, Shaw JLV, Colantonio DA, Ramsay T, Goupil R

    Subclinical Primary Aldosteronism and eGFR Decline Over Time

    J Am Soc Nephrol 2026.

  • article Hundemer GL, Agharazii M, Madore F, Piché ME, Gagnon C, Bussières A, St-Jean M, Leung AA, Kline GA, Sood MM, Burger D, Ramsay T, Goupil R

    Sex-specific Associations of Aldosterone and Renin With Body Composition: A Population-based Cohort Study

    J Clin Endocrinol Metab 110 (3), 2025.

  • article Tairi A, Obeid H, Addour S, Butlin M, Avolio AP, Fortier C, Agharazii M

    Assessing the Validity of Computerized Algorithms for Determining Pulse Wave Velocity: A Clinical Study

    Pulse (Basel) 13 (1), 2025.

  • article Goupil R, Desbiens LC, Merabtine A, Agharazii M, Madore F, Vaidya A, Leung AA, Kline GA, Shaw JLV, Ramsay T, Nadeau-Fredette AC, Sood MM, Hundemer GL

    Subclinical Primary Aldosteronism and Major Adverse Cardiovascular Events: A Longitudinal Population-Based Cohort Study

    Circulation 152 (13), 2025.

  • article Zhou J, Williams C, Staplin N, Judge PK, Mayne KJ, Agrawal N, Arimoto R, Green JB, Cherney DZI, Tuttle KR, Leal J, Clarke P, Emberson JR, Preiss D, Wanner C, Landray MJ, Baigent C, Haynes R, Herrington WG, Mihaylova B and

    Effects of empagliflozin on quality of life and healthcare use and costs in chronic kidney disease: a health economic analysis of the EMPA-KIDNEY trial

    EClinicalMedicine 85 2025.

  • article Ziasaeedi N, Lemaréchal Y, Agharazii M, Manem VSK, Després P, Ebrahimpour L

    Radiomics-based kidney lesion classification: Mitigating batch effect with nested combat harmonization

    Med Phys 52 (9), 2025.

  • article Bruno RM, Badhwar S, Abid L, Agharazii M, Anastasio F, Bellien J, Burghuber O, Faconti L, Ghiadoni L, Giannattasio C, Hametner B, Hughes AD, Ikonomidis I, Lonnebakken MT, Maloberti A, Mayer CC, Muiesan ML, Paini A, Panayiotou A, Park C, Rajkumar C, Becerra CR, Spronck B, Terentes-Printzios D, Weber T, Boutouyrie P and

    Accelerated vascular ageing after COVID-19 infection: the CARTESIAN study

    Eur Heart J 46 (39), 2025.

  • article Walsh M, Collister D, Gallagher M, Mark PB, de Zoysa JR, Tyrwhitt J, Tennankore K, Reis G, Xavier D, Liu WJ, Zuo L, Wang AY, Félix C, Sola L, Arici M, Villanueva R, Jha V, Précoma D, Rabbat CG, Alavudeen SS, Faruqui AR, López-Flecher M, Pyne L, Wald R, Yuan F, Balasubramanian K, Lee SF, Kuptsova A, Christou C, Devereaux PJ and

    Spironolactone versus placebo in patients undergoing maintenance dialysis (ACHIEVE): an international, parallel-group, randomised controlled trial

    Lancet 406 (10504), 2025.

  • article Paré M, Zola N, Coudert L, Phaneuf JC, Lavallée R, Caplette-Gingras A, Fortier C, Agharazii M

    A mixed-methods protocol to explore psychological distress and psychosocial needs along the continuum of CKD care- a single healthcare network

    BMC Nephrol 26 (1), 2025.

  • article Desbiens LC, Veillette S, Fortier C, Nadeau-Fredette AC, Hametner B, Wassertheurer S, Madore F, Agharazii M, Goupil R

    Prediction of cardiovascular events by algorithm- and formula-based pulse wave velocity

    J Hypertens 44 (1), 2026.

  • article Côté N, Fortier C, Desbiens LC, Nemcsik J, Agharazii M

    Individual versus integration of multiple components of central blood pressure and aortic stiffness in predicting cardiovascular mortality in end-stage renal diseases

    J Hum Hypertens 38 (5), 2024.